Cell proliferation markers at the invasive tumor front of oral squamous cell carcinoma: comparative analysis in relation to clinicopathological parameters of patients by CORTEGOSO, Aurita Veronica Beovide et al.
318J Appl Oral Sci.
Abstract
Submitted: May 21, 2016
???????????????????????????????
Accepted: September 26, 2016
Cell proliferation markers at the 
invasive tumor front of oral squamous 
cell carcinoma: comparative analysis 
in relation to clinicopathological 
parameters of patients
Objectives: To evaluate the number of AgNORs per nucleus and the 
expression of Ki-67 at the tumor invasion front (TIF) in relation to clinical 
????????????????????????????????????????????????????????????????????????????
carcinomas in an Uruguayan population. Material and Methods: This study 
was conducted through a retrospective survey from 2000 to 2010 at the 
National Institute of Cancer Montevideo, Uruguay and included 40 patients. 
The samples were obtained from the resection of the tumor and the TIF was 
????????????????? ?????????????????5 (1992). Expression of Ki-67 was assessed 
by the percentage of positive tumor cells and the AgNOR was recorded as the 
mean AgNOR (mAgNOR) and the percentage of AgNOR per nucleus (pAgNOR). 
All analyzes were performed by a blinded and calibrated observer. Results: 
???????????????????????????????????????? ????????????????????? ?????????????
of Ki-67 and AgNOR with the different types of TIF, regional metastasis and 
patients prognosis, however it was observed an increase in Ki-67 expression 
associated with worse patient’s clinical staging, although not statistically 
???????????????????????????????????????????????????????????????????????????
AgNOR and Ki-67 are not prognostic markers at the tumor invasive front of 
carcinoma of oral squamous cell.
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Introduction
Oral cancer is a important global health disease 
with more than 300,000 new cases annually, totalizing 
over 275,000 cases and 128,000 deaths per year 
and the morbidity and mortality rates have not 
improved in the past decades18. Studies have shown 
different patterns of oral squamous cells carcinomas 
in the various regions of the world, but few studies 
have evaluated this neoplasm in the Uruguayan 
population2,9. In addition, in Uruguay oral squamous 
cell carcinoma (OSCC) is diagnosed late, which 
provides poor prognosis and low survival rate for this 
disease20.
The high failure rate of treatment for patients with 
oral OSCC suggests the need for better prognostic 
markers to identify aggressive tumors and tumors that 
do not respond well to current therapy3. The prognostic 
evaluation by the TNM system is limited because it 
only evaluates clinical parameters and do not take into 
account the histopathological characteristics, neither 
the tumor-host interrelationship5,17,26.
The histological features of the OSCC can be 
widely different from one area to another within the 
same tumor. It is believed that the most useful site 
for predicting prognosis is the forehead area of tumor 
invasion front (TIF) as it would presumably reside 
????? ??????????? ???????????????????????? ???? ????????
various molecular interactions that are crucial for 
the progression of cancer: increased angiogenesis, 
alteration of adhesion molecules, overproduction of 
enzymes that degrade the extracellular matrix and 
an increase in the expression of proteins related to 
cell proliferation1,4,5. The analysis of morphological 
features such as: degree of keratinization, nuclear 
polymorphism, pattern of invasion and lymphocytic 
?????????????????????????????????????????????????????
as a supplement to the TNM4,5,17.
Rapidly growing tumors proved to be deeply 
invasive and with a poorer prognosis compared with 
slow-growing tumors. Experimental evidence suggests 
that the degree of cell proliferation in a tumor is an 
indicator for estimating biological aggressiveness12,29. 
The increased proliferative capacity may be an early 
indicator of malignant transformation, and, thus, 
relevant to analyze the tumor prognosis7,11.
Proliferative markers such as argyrophilic nucleolar 
organizer regions (AgNORs) and Ki-67 have been used 
??????????????????????????????????????????26,29. The 
AgNOR technique consists of silver impregnation of 
proteins associated with the active nucleoli organizer 
regions (NORs). Ki-67 is a nuclear antibody that 
recognizes non-quiescent cells. AgNOR and Ki-67 can 
provide valuable information about cell proliferation 
velocity in tumors25, and the total fraction of 
proliferating cells, respectively10,17,29.
This theme has been studied by other authors, 
however so far results are contradictory17,21,22,28. To 
our knowledge, there are no studies in the English 
literature evaluating concomitantly these proliferation 
markers (Ki-67 and AgNOR) in TIF in order to predict 
overall prognosis in OSCC as assessed in our study. So 
the aim of this research is to evaluate cell proliferation, 
through the analysis of the number of AgNORs per 
nucleus and the expression of Ki-67, in the tumor 
invasion front in comparison with clinical parameters 
??????????????????????????????????????????????????????
an Uruguayan population.
Material and methods
This study was conducted through a retrospective 
survey of the period between January 2000 and 
December 2010, in the Laboratory of Pathology 
Anatomy Cancer Institute (INCA) (Montevideo, 
Uruguay) and approved by the local Ethics Committee 
with approval protocol number decree 379/08, 
expedient 091900/000274-13. 109 cases of OSCC 
were found, of whom 40 met all the inclusion criteria: 
intra-oral tumors (tumors from lip and oropharynx 
were excluded), complete clinical data (gender, 
age, location, TNM), pathology data (clinical stage, 
degree of differentiation), a clearly demonstrated 
????????? ????????????????????????? ??????????????????
????????????????????????????????????????????????????
because did not meet all the inclusion criteria or due 
to extensive areas of necrosis and poor preservation 
of the histological structures.
All patients underwent surgical treatment followed 
by radiotherapy and/or chemotherapy. Samples were 
obtained from the resection of the tumor, and the TIF 
??????????????????????????????????????????????????????
with a normal range of connective tissue. The gender, 
age, location data TNM, clinical staging and evolution 
???????????????????????????????????????????????????????
?????????????????????????????????????????????????
(T2 N0M0); Stage III (T1,T2,N1 and M0 or T3,N0,N1 
and M0); Stage IVa (T1, T2, T3, N2 and M0 or T4a, 
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N0, N1,N2 and M0)13.
Serial sections from tissue samples, 3 μm in 
??????????? ????? ????????? ????? ?????????????????
samples. The first was stained with hematoxylin 
????????????????????????????????????????????????????
according to Bryne, et al.5 (1992). For each tumor, 
the degree of keratinization, nuclear polymorphism, 
??????????????????????????????????????????????????????
were graded and given scores between 1 and 4. The 
scores were summed into a total score with variable 
???????????????? ???????? ?????? ???? ??????? ???? ????
(good); 9-12 (moderate) and 13-16 (poor). The 
second section was submitted to immunohistochemical 
method for the detection of Ki-67 and the third was 
silver-stained for the detection of AgNORs.
Immunohistochemistry
The samples were dewaxed and processed for 
???????? ?????????? ?????????? ???????? ??? ?????? ???? ??
minutes). Endogenous peroxidase was blocked by 
incubation in 3% hydrogen peroxide in methanol. After 
washing, the sections were incubated with primary 
antibody Ki-67, concentration 1:25, (monoclonal 
anti-human, clone MIB-1, DakoCytomation; Glostrup, 
Denmark). Envision (DakoCytomation; Carpinteria, 
CA, EUA) and diaminobenzidine tetrahydrochloride 
(DAB, DakoCytomation; Carpinteria, CA, EUA) were 
????? ??? ??????? ???????? ????????? ???? ??????????????
counterstained with hematoxylin of Harris, dehydrated 
and mounted. Positive control was obtained according 
to the manufacturer.
Microscopic images were captured with an Olympus 
binocular microscope equipped with an Olympus® 
video camera [QColor 5, Coolet, RTV and a Dell 
computer (Dimension 5150)]. Image J software 
(National Institutes of Health, Bethesda, MD, EUA) 
was used to count Ki-67 positive cells. 1000 cells were 
?????????????????????????????????????????????????????????
Cells with a brown nucleus were considered positive, 
regardless of the intensity of the color.
AgNOR
The samples were subjected to the AgNOR 
technique following the protocol described by Ploton, 
et al.24 ???????????????????????????????????????????
the criteria established by Crocker et al.8 (1988). The 
????? ??????????????????? ???????????????? ??????????
?????? ????? ????????? ??? ??????????????????? ??????
immersion oil. AgNOR dots per????????? ??????????????
on the images captured. Mean AgNORs per nucleus 
(mAgNOR) in each sample, and the percentage 
AgNORs per nucleus (pAgNOR>1, pAgNOR>2, 
pAgNOR>3, pAgNOR>4) were calculated according 
to the methodology proposed by Xie, et al.30 (1997).
Statistical analysis
All quantification of Ki-67 and AgNORs was 
performed by a single blinded observer, and the 
grading scores in TIF were performed by two 
pathologists (Kappa=0.87).
Statistical analysis was performed using Software 
GraphPad Prims 5 (GraphPad Software,Inc.; La 
Variables n %
Age ??? 17 42.5
<60 23 57.5
Sex Men 31 77.5
Woman 9 22.5
Location Tongue 20 50.0
Palate 6 15.0
Buccal mucosa 7 17.5
Floor of the mouth 2 5.0
Trigon retromolar 5 12.5
Evolution Live 17 42.5
Dead 23 57.5
T 1 0 0.0
2 17 42.5
3 15 37.5
4 8 20.0
N N0 24 60.0
N1 8 20.0
N2 6 15.0
N2b 1 2.5
N2c 1 2.5
M M0 40 100.0
Clinical Staging I 0 0.0
II 12 30.0
III 14 35.0
IV 14 35.0
Table 1- Clinicopathological features of the tumor samples
???????? ?????? ?????? ????????? ?????? ????? ????????????
N1=Metastasis in a single ipsilateral lymph node, 3 cm or less in 
??????????? ?????????????????????? ???????????? ???????????? ??????
?????????????????????????????????????????????????????? ????????
multiple ipsilateral lymph nodes, none more than 6 cm in greatest 
dimension, bilateral or contralateral lymph nodes, no more than 6 
????????????????? ??????????????????????????????????????????????
????? ????? ????? ?? ??? ??? ????????? ?? ???????? ???????????????
in bilateral or contralateral lymph nodes, no larger than 6 cm in 
??????????? ???????????????????????????????????????????????????
??????????????????????? ?????? ???????????????? ?????? ?????????
??????????????????????????????????????????????????????????????
T3, N2 and M0 or T4a, N0, N1, N2 and M0
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Jolla, CA, USA). According to date distribution, the 
comparison of Ki-67 immunostaining and AgNORs was 
performed by ANOVA followed by post hoc Tukey test. 
?????????????????????????????? ???????????????????????
Results
The sample was composed of patients with mean 
age of 63.3 years, ranging from 40 to 91 years. Most 
of them were men (77.50%), the tongue was the 
preferred location (50%) and most of the tumors 
were T2 (42.50%). No lymph node metastasis (N0) 
was detected in 60% cases. Regarding the evolution 
of patients, 57.50% of patients died by the tumor. 
Clinicopathological features of the 40 tumors samples 
are summarized in Table 1.
???????????????????????????????????????? ????????????
between immunostaining of Ki-67 and AgNOR with 
different types of TIF (Figure 1, Table 2). An increase 
in Ki-67 mean associated with worse patient’s 
clinical staging was noted, although not statistically 
????????????????????? ??????????????????????????????
(died because of the tumor) showed lower mAgNOR 
?????????????? ????????? ??? ????????? ????? ?????
?????????? ??????????????? ???? ????????? ?????????
????????????????????????????????????????
Parameters Mean % Ki-67 mAgNOR pAgNOR>1 pAgNOR>2 pAgNOR>3 ????????
?????????????????
TIF [Bryne, et al.5 
(1992)]
Good 23.30(±14.01) 1.903(±0.2881) 57.64(±13.33) 24.82(±11.72) 7.54(±5.06) 0.18(±0.40)
Moderate 22.91(±11.71) 1.909(±0.4910) 52.90(±18.11) 24.97(±18.16) 10.73(±13.13) 0.86(±1.69)
Poor 19.26(±11.54) 1.923(±0.2318) 57.29(±11.28) 27.29(±11.19) 7.14(±3.93) 0.42(±0.78)
p 0.7826 0.6651 0.5407 0.6131 0.9951 0.6142
Clinical Staging
II 19.49(±13.32) 1.869(±0.4277) 55.00(±17.74) 24.75(±16.10) 8.75(±7.65) 0.91(±1.24)
III 22.43(±11.66) 2.000(±0.3328) 57.63(±12.60) 28.36(±13.73) 11.43(±9.71) 0.92(±2.05)
Iva 27.20(±14.00) 1.964(±0.5232) 57.36(±16.57) 26.07(±19.74) 10.07(±15.78) 0.35(±1.08)
p 0.4985 0.5854 0.9049 0.6705 0.5147 0.3300
Regional Metastasis
N0 23.97(±12.56) 2.023(±0.4705) 58.71(±17.53) 30.29(±18.31) 11.06(±8.62) 0.79(±1.64)
N+ 20.21(±13.31) 1.836(±0.3368) 52.81(±13.39) 20.75(±11.16) 9.47(±13.39) 0.62(±1.36)
p 0.4205 0.1717 0.2189 0.1032 0.1978 0.7923
Patients Evolution
Live 23.60(±12.85) 2.075(±0.5081) 61.18(±18.04) 32.65(±20.27) 13.12(±15.59) 0.52(±1.73)
Died 22.23(±12.93) 1.854(±0.3382) 52.78(±13.81) 21.91(±11.20) 7.95(±6.75) 0.86(±1.35)
p 0.7914 0.1713 0.1186 0.0977 0.4934 0.0917
Table 2- Proliferative markers, percentage of Ki-67 positive cells and AgNOR, according to Bryne et al.5 (1992) histological malignancy 
grade of the TIF (tumor invasion front), clinical staging of the tumor, regional metastasis and patient evolution. Legend: mAgNOR=average 
AgNOR per?????????????????????????????????????per????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
N+=presence regional metastasis
Figure 1- Photomicrography of stained sections of TIF. Good differentiation (A, D), Moderate differentiation (B, E) and poor differentiation 
(C, F). According to AgNOR staining (A, B, C), 1000x, or Ki-67 immunostaining (D, E, F), 400x
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In relation to regional metastasis, the mean of 
Ki-67 and AgNOR in the N0 tumor group was higher 
than in the N+ tumor group, although not statistically 
?????????????????????
Discussion
The TIF is characterized by cells with a lower degree 
of differentiation and a higher degree of cell dissociation 
compared to other parts of the tumor. These cells are 
more aggressive and tend to invade and metastasize. 
Recent studies suggest that cells presented at the TIF 
have different molecular characteristics than those in 
??????????????????????????????????????????? ????????
prognostic area of the tumor1,4,5. The proliferative 
activity analysis at the TIF has been studied as an 
attempt to predict the biological behavior of tumor, 
as well as the possibility of local recurrence and 
metastatic potential. However, the proliferative activity 
at TIF association with clinical pathological parameters 
remains controversial16,17,26.
The cell proliferation markers Ki-67 and AgNOR 
in TIF of oral cancer were evaluated in a total of 9 
studies so far10,17,19,21-23,26,28,29. The association with 
prognosis was evaluated in 5 of these studies, however 
contradictory results have been observed21-23,26,29. In 
our study it was not observed a clear relationship 
between prognosis, regional metastasis and cell 
proliferation at the TIF assessed by immunostaining 
of Ki -67 and AgNOR counting.
Regarding the clinical evolution, we observed a 
lower AgNOR counts and Ki-67 positive cells in TIF of 
patients with worse prognosis, although not statically 
???????????????????????????????????????????????????????
Piffko, et al.22 (1997) which observed that OSCC with 
favorable prognosis contained lower mean AgNOR at 
the TIF than patients with poor prognosis. This may 
be due to different methodology, different sample 
sizes, or a combination of these factors, which could 
explain the differences between our studies. Piffko, 
et al.22 (1997) performed a morphometric analysis of 
AgNOR, whereas we performed a quantitative analysis.
??????????????????????????????????????????????????????
observed for clinical staging of tumors and proliferative 
activity of the TIF. Our results demonstrated a 
tendency of higher mean Ki-67 positive cells in patients 
with worse clinical staging (stage IV), (not statistically 
????????????? ?????? ???????? ???? ??? ???????????????
Tumulari, et al.26 (2004), which showed that advanced 
stage clinical (stages III and IV) of the OSCC presented 
a higher mean of Ki-67 staining when compared the 
early stage of the disease (stage I and II). However, 
these results disagree with Piffkó, et al.23 (1996), 
who studied Ki-67 at TIF and Watanabe, et al.29 
(2010), which noted that the Ki-67 expression was 
not correlated with clinicopathological features such 
as survival and clinical staging of OSCC.
Gonzalez-Moles, et al.15 (2010), reported that the 
Ki-67 has no prognostic value in oral cancer, although 
the authors did not evaluate this marker at the TIF. 
This can be explained because Ki-67 is a marker of 
the total fraction of proliferating cells, expressed in all 
cell cycle phases, excepted G0, being negative to cells 
in quiescence. Other explanation is that only a small 
group of cells within the tumor would be responsible 
for the malignant growth, corresponding to cells in 
constant proliferation, and the expression of Ki-67 
?????????????????????????????????????????????????????????
what could explain the lack of prognostic value of Ki-
67 expression6,14.
The results of the present study suggest that 
the invasive front cells could expend more energy 
to perform migration and invasion process than to 
performing cell division. During the tumor invasion, 
cells undergo epithelial mesenchymal transition, 
what gives them migratory and invasive properties. 
The acquired mesenchymal phenotype implies the 
reorganization of the cytoskeleton what may be 
incompatible with high cell proliferation27. Accordingly 
with our results, Pereira, et al.21 (2016) observed low 
Ki-67 expression in the TIF and suggests that this may 
be due to the analysis of cell proliferation has only been 
performed in TIF, so we can infer that proliferative 
??????????????????????????????????????????????????????
by other factors the tumor microenvironment.
Different results between this study and the 
literature could be explained by differences in criteria 
???? ????????????????????????????????????????????????
?????????????????????????????????????????????????????
analysis of immunostaining. Another explanation is 
that oral cancer may behave differently around the 
???????????????????????????????????????????????????????????
markers in an Uruguayan population.
Many aspects may be necessary to establish the 
real prognosis of OSCC including: clinical staging, the 
presence of distant metastasis, depth of tumor, location 
of tumor and perineural invasion17. In other words, the 
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????????????????????????????????????????????????????????
the characteristics of the entire tumor. Furthermore, 
the tumors consist of a heterogeneous cell population 
with biological behavior variable depending on a 
complex interplay between host and tumor16,17.
In conclusion, our results demonstrated that the 
proliferation at the TIF in OSCC measured by Ki-67 
and AgNOR, is not useful to predict patient prognosis. 
Further studies should be performed in order to clarify 
whether the tumor invasive front analysis is directly 
related to prognosis.
????????????????????
??? ?????????? ???????? ??? ????????? ????????? ??? ?????
article is reported.
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